AR027430A1 - Nuevos compuestos de acido 6-amino o 6-hidracino-sulfonil-3-quinolil-fofonico, un procedimiento para su preparacion - Google Patents

Nuevos compuestos de acido 6-amino o 6-hidracino-sulfonil-3-quinolil-fofonico, un procedimiento para su preparacion

Info

Publication number
AR027430A1
AR027430A1 ARP010100677A ARP010100677A AR027430A1 AR 027430 A1 AR027430 A1 AR 027430A1 AR P010100677 A ARP010100677 A AR P010100677A AR P010100677 A ARP010100677 A AR P010100677A AR 027430 A1 AR027430 A1 AR 027430A1
Authority
AR
Argentina
Prior art keywords
hydraacino
fofonico
quinolil
sulfonil
amino
Prior art date
Application number
ARP010100677A
Other languages
English (en)
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR027430A1 publication Critical patent/AR027430A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/60—Quinoline or hydrogenated quinoline ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Compuestos de la formula (1) donde R1 representa un átomo de halogeno o un grupo CF3, R2 representa un átomo de hidrogeno o un grupo alquilo o cicloalquiloR3 se define como en la descripcion, R4 y R5 representan un átomo de hidrogeno o un grupo alqui lo, cicloalquilo, arilo o arilalquilo o un grupo (2). Loscompuestos son antagonistas no-NMDA e inhibidores AMPA.
ARP010100677A 2000-02-18 2001-02-15 Nuevos compuestos de acido 6-amino o 6-hidracino-sulfonil-3-quinolil-fofonico, un procedimiento para su preparacion AR027430A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0002012A FR2805261A1 (fr) 2000-02-18 2000-02-18 Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
AR027430A1 true AR027430A1 (es) 2003-03-26

Family

ID=8847123

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100677A AR027430A1 (es) 2000-02-18 2001-02-15 Nuevos compuestos de acido 6-amino o 6-hidracino-sulfonil-3-quinolil-fofonico, un procedimiento para su preparacion

Country Status (19)

Country Link
US (1) US6486143B2 (es)
EP (1) EP1125942B1 (es)
JP (1) JP2001270890A (es)
KR (1) KR20010082702A (es)
CN (1) CN1320601A (es)
AR (1) AR027430A1 (es)
AT (1) ATE236912T1 (es)
AU (1) AU2304201A (es)
BR (1) BR0100601A (es)
CA (1) CA2337785A1 (es)
DE (1) DE60100166D1 (es)
EA (1) EA200100155A3 (es)
FR (1) FR2805261A1 (es)
HK (1) HK1040518A1 (es)
HU (1) HUP0100749A3 (es)
NO (1) NO20010801L (es)
NZ (1) NZ510000A (es)
PL (1) PL345916A1 (es)
ZA (1) ZA200101340B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805260A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-sulfamoyl-3-quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2899473B1 (fr) * 2006-04-07 2008-06-13 Servier Lab Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires
CN108484668A (zh) * 2018-04-25 2018-09-04 中山大学 具有磺酰基官能团的有机膦化合物及其制备方法和应用
CN108467409A (zh) * 2018-04-25 2018-08-31 中山大学 具有磺酰基官能团的五价膦化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683818B1 (fr) * 1991-11-14 1993-12-31 Adir Cie Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5342946A (en) * 1992-12-02 1994-08-30 Guilford Pharmaceuticals Inc. Phosphonoalkylquinolin-2-ones as novel antagonists of non-NMDA ionotropic excitatory amino acid receptors
FR2709489B1 (fr) * 1993-08-31 1995-10-20 Adir Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2750988B1 (fr) * 1996-07-11 1998-09-18 Adir Nouveaux derives de 2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HU0100749D0 (en) 2001-04-28
JP2001270890A (ja) 2001-10-02
HUP0100749A3 (en) 2002-09-30
US20010031746A1 (en) 2001-10-18
HK1040518A1 (zh) 2002-11-08
HUP0100749A2 (hu) 2002-01-28
US6486143B2 (en) 2002-11-26
NZ510000A (en) 2001-12-21
FR2805261A1 (fr) 2001-08-24
KR20010082702A (ko) 2001-08-30
AU2304201A (en) 2001-08-23
NO20010801L (no) 2001-08-20
BR0100601A (pt) 2001-09-18
PL345916A1 (en) 2001-08-27
EP1125942B1 (fr) 2003-04-09
CA2337785A1 (fr) 2001-08-18
CN1320601A (zh) 2001-11-07
ZA200101340B (en) 2001-08-22
ATE236912T1 (de) 2003-04-15
NO20010801D0 (no) 2001-02-16
EA200100155A2 (ru) 2001-08-27
EA200100155A3 (ru) 2001-10-22
EP1125942A1 (fr) 2001-08-22
DE60100166D1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
ATE158269T1 (de) Verfahren zur herstellung von cyclopentadien- derivaten
WO2002064616A3 (en) Agonists and antagonists of sphingosine-1-phosphate receptors
MY126059A (en) Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest controllers and a method for using the same
AR248018A1 (es) Procedimiento para preparar compuestos de (1h)-bencimidazol-2-il-piperidinilmetanona.
DE60318583D1 (de) N-äphenyl(piperidin-2-yl)methylübenzamid-derivate, verfahren zu deren herstellung und ihre therapeutische verwendung
CY1109691T1 (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ Ν-ΜΟΝΟΫΠΟΚΑΤΕΣΤΗΜΕΝΩΝ β-ΑΜΙΝΟ ΑΛΚΟΟΛΩΝ
ATE267176T1 (de) 6,7-asymmetrisch disubstituierte chinoxalincarbonsäurederivate, additionssalze davon und verfahren zur herstellung von beiden
MX9806246A (es) PIPERIDINAS NOVEDOSAS DERIVADAS DE 1-/(PIPERAZIN-1-IL)ARIL-(OXI/AMINO)CARBONIL(4-ARIL-PIPERIDIN A COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR 5-HT-1D- beta-.
YU46664B (sh) Novi 2-(2-supstituisani benzoil)-4-supstituisani oksi ili supstituisani tio)-1,3-cikloheksandioni i postupak za njihovo dobijanje
CO5190683A1 (es) Analogos de vitamina d3
AR027430A1 (es) Nuevos compuestos de acido 6-amino o 6-hidracino-sulfonil-3-quinolil-fofonico, un procedimiento para su preparacion
DE3762416D1 (de) Dihydropyridinverbindungen, verfahren zu ihrer herstellung und ihre verwendung.
ATE390432T1 (de) Phosphinverbindung, zwischenverbindung, palladiumkomplex, und deren verwendung
YU33490A (sh) Antivirusna tetrahidroimidazo (1,4)benzodiazepin-2-tiona jedinjenja i postupak za njihovo dobijanje
PE20030539A1 (es) Derivados de piperazina antagonistas de los receptores de somatostatina sst1
ES545936A0 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina e isoquinolina
ATE272600T1 (de) Verfahren zur herstellung von alkoxy- oder arylmethoxy-aroxyethanen
TR200402547T4 (tr) Pantoprazol ve ara maddelerini hazırlamak için bir işlem.
ES2061162T3 (es) Compuestos herbicidas.
DE69910101D1 (de) Verfahren zur Herstellung von Opiaten
ATE348810T1 (de) Verfahren zur herstellung von 2-aminomethyl- halogen-pyridinen
AR023506A1 (es) Proceso para la preparacion de pirimidinas sustituidas.
ES2078532T3 (es) Plaguicidas a base de etinilbenzotiofeno.
ATE309198T1 (de) Fungizide mit einer fluorovinyl-oder fluoropropenyloxyphenyloxim-einheit und ein verfahren zu ihrer herstellung.
CO5690562A2 (es) Metodos para la preparacion del acido {2-[(8,9)-dioxo-2-6-diazabiciclo[5.2.0] non-1(7)-en-2-il]} fosfonico y sus esteres

Legal Events

Date Code Title Description
FB Suspension of granting procedure